| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 05/08/2002 | CN1084332C Active oxygen scavengers containing pterin derivatives |
| 05/02/2002 | WO2001085165A3 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system |
| 05/02/2002 | EP1200437A1 Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 05/02/2002 | EP1200436A1 Method for making pure stereoisomers of tetrahydrofolic acid ester salts and tetrahydrofolic acid by fractionated crystallisation of tetrahydrofolic acid salts |
| 05/02/2002 | DE10051628A1 Mittel zur Inaktivierung von pathogenen Keimen und dessen Verwendung Means for inactivation of pathogenic microorganisms and the use thereof |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/25/2002 | WO2002032875A1 Agent which inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof |
| 04/25/2002 | WO2002032507A1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 04/25/2002 | US20020049163 Nucleosidic and non-nucleosidic folate conjugates |
| 04/25/2002 | US20020049154 Bioconjugates and delivery of bioactive agents |
| 04/18/2002 | US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates |
| 04/11/2002 | WO2001084962A3 Compositions containing folic acid and reduced folate |
| 04/03/2002 | EP1193257A2 Compounds for ceramide-mediated signal transduction |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 03/28/2002 | DE10046267A1 Pesticides comprising flavine derivatives, e.g. riboflavin, having chitinase inhibiting activity, useful e.g. as insecticides, acaricides, nematocides, fungicides, ectoparasticides or antifouling agents |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/20/2002 | EP1187615A2 Immunosurpressive effects of pteridine derivatives |
| 03/19/2002 | US6359148 For polymer, lubricants; heat, oxidation resistance, photostability |
| 03/19/2002 | US6358953 Administering pterin metal complex as anticarcinogenic agents and viricides |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028813 Isoquinoline inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose) polymerase (PARP); treat tissue damage from necrosis or apoptosis, ischemia or reperfusion injury, stroke, senescence diseases |
| 03/06/2002 | EP0760818B1 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/21/2002 | US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 02/20/2002 | EP1180369A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |
| 02/19/2002 | US6348593 Process for preparing folic acid |
| 02/12/2002 | US6346630 3-Arylbenzofuranones as stabilizers |
| 02/06/2002 | CN1334815A Methotrexate derivatives |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2002 | WO2000045800A3 Immunosurpressive effects of pteridine derivatives |
| 01/02/2002 | EP1165566A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 01/01/2002 | US6335434 Nucleosidic and non-nucleosidic folate conjugates |
| 12/27/2001 | WO2001034614A3 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 12/13/2001 | WO2001093841A2 Barbituric acid analogs as therapeutic agents |
| 12/06/2001 | WO2001091807A2 Ethylenedicysteine (ec)-drug conjugates |
| 12/05/2001 | EP0934363B1 Process for colouring high molecular weight organic material and polycyclic pigments |
| 11/27/2001 | US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders. |
| 11/27/2001 | US6323205 Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors |
| 11/27/2001 | US6323201 Compounds for inhibition of ceramide-mediated signal transduction |
| 11/22/2001 | WO2001087299A1 Aralkyl ester soft drugs |
| 11/22/2001 | CA2407099A1 Aralkyl ester soft drugs |
| 11/21/2001 | EP1154997A1 Pharmaceutically active compounds and methods of use thereof |
| 11/15/2001 | WO2001085165A2 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system |
| 11/15/2001 | WO2000064484A3 Conjugate having a cleavable linkage for use in a liposome |
| 11/15/2001 | DE10022856A1 Treating central nervous system disorders e.g. cognitive deficiency or depression, using combination of lipoic acid and C-1 donor e.g. S-adenosyl-methionine |
| 11/15/2001 | DE10022510A1 Composition used as folate source in food, feed, nutritional supplements or medicaments, e.g. for prophylaxis of cardiovascular disease includes folic acid and 5-methyl-tetrahydrofolic acid |
| 11/15/2001 | CA2408666A1 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system |
| 11/13/2001 | US6315978 Bioconjugates and delivery of bioactive agents |
| 10/31/2001 | CN1074013C 3-arylbenzofuranones as stabilisers and its use |
| 10/17/2001 | EP1144412A1 Immunosuppressive effects of pteridine derivatives |
| 10/17/2001 | EP1143991A2 Inhibitors of h+k+ -atpase |
| 10/17/2001 | EP1143974A1 Pharmaceutical compositions for alleviating discomfort |
| 10/10/2001 | EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 10/04/2001 | WO2001073438A1 Ricin inhibitors and methods for use thereof |
| 09/27/2001 | US20010025043 New pharmaceutical active compounds |
| 09/27/2001 | US20010024781 Substituted-2,3,4,10-tetrahydrobenzo(g)pteridin-2,4-diones; decontamination of blood, protein and blood products as well as other fluids such as juices, and surfaces of food, carcasses, bathing surfaces |
| 09/26/2001 | EP1135390A1 Methotrexate derivatives |
| 09/18/2001 | US6291673 Useful intermediates in the synthesis of folic acid conjugates capable of binding folate receptors in vitro and in vivo |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288067 Prophylactic or therapeutic agents for drug-induced renal injury |
| 08/30/2001 | WO2001062758A1 Pteridine compounds for the treatment of psoriasis |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/28/2001 | US6281376 Therapeutic compound—fatty acid conjugates |
| 08/23/2001 | WO2001060821A1 Novel biarylcarboxamides |
| 08/23/2001 | CA2397233A1 Biarylcarboxamides |
| 08/22/2001 | EP1124548A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP0632038B1 Methotrexate derivative |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | CA2039855C Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| 08/21/2001 | CA2013324C Pteridin-4(3h)-ones, process for their preparation and drugs containing them |
| 08/16/2001 | EP1123294A1 Novel pterin antineoplastic agents |
| 08/09/2001 | WO2001057020A1 INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa |
| 08/07/2001 | US6271374 Stable crystalline (6S)- and (6R)-tetrahydrofolic acid |
| 08/07/2001 | US6271231 Pharmaceutically active compounds |
| 08/02/2001 | WO2001055095A1 Functional monomers for molecular recognition and catalysis |
| 07/31/2001 | US6268120 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/18/2001 | EP1116721A1 Process for the reduction of pterines |
| 07/18/2001 | EP1115710A1 Process for preparing regiospecific substituted pyrazine isomers |
| 07/18/2001 | CN1304402A Sulfonamide derivatives |
| 07/18/2001 | CN1068593C Process for preparing 2-alkoxyphenoxy sulfuric urea with heterocylic ring |
| 07/11/2001 | EP0679398B1 Immunopotentiating and infection protective agent and production thereof |
| 07/10/2001 | CA2175502C Cyclic amide derivatives |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/20/2001 | CN1067392C Stable crystalline tetrahydrofolic acid salts |
| 06/13/2001 | EP0805812B1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/06/2001 | EP0839211B1 Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity |
| 06/06/2001 | EP0681584B1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |